Osaic Holdings’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $278K | Buy |
15,136
+3,093
| +26% | +$56.9K | ﹤0.01% | 3324 |
|
2025
Q1 | $232K | Sell |
12,043
-1,484
| -11% | -$28.6K | ﹤0.01% | 3505 |
|
2024
Q4 | $241K | Buy |
13,527
+1,488
| +12% | +$26.6K | ﹤0.01% | 3434 |
|
2024
Q3 | $264K | Buy |
12,039
+11,589
| +2,575% | +$254K | ﹤0.01% | 3429 |
|
2024
Q2 | $3.51K | Sell |
450
-11,411
| -96% | -$89K | ﹤0.01% | 6216 |
|
2024
Q1 | $49.1K | Sell |
11,861
-132,095
| -92% | -$547K | ﹤0.01% | 4749 |
|
2023
Q4 | $376K | Sell |
143,956
-25,622
| -15% | -$66.9K | ﹤0.01% | 3396 |
|
2023
Q3 | $317K | Buy |
169,578
+1,200
| +0.7% | +$2.24K | ﹤0.01% | 3641 |
|
2023
Q2 | $423K | Buy |
168,378
+12,809
| +8% | +$32.2K | ﹤0.01% | 3287 |
|
2023
Q1 | $272K | Buy |
155,569
+109,395
| +237% | +$191K | ﹤0.01% | 3618 |
|
2022
Q4 | $197K | Buy |
46,174
+5,800
| +14% | +$24.7K | ﹤0.01% | 3852 |
|
2022
Q3 | $48K | Buy |
40,374
+29,774
| +281% | +$35.4K | ﹤0.01% | 4933 |
|
2022
Q2 | $11K | Buy |
10,600
+1,000
| +10% | +$1.04K | ﹤0.01% | 6009 |
|
2022
Q1 | $24K | Sell |
9,600
-150
| -2% | -$375 | ﹤0.01% | 5566 |
|
2021
Q4 | $26K | Sell |
9,750
-1,330
| -12% | -$3.55K | ﹤0.01% | 5602 |
|
2021
Q3 | $56K | Buy |
11,080
+5,100
| +85% | +$25.8K | ﹤0.01% | 5015 |
|
2021
Q2 | $44K | Buy |
+5,980
| New | +$44K | ﹤0.01% | 5134 |
|